Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6791560
[patent_doc_number] => 20030086904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Therapeutic regimen for treating cancer'
[patent_app_type] => new
[patent_app_number] => 10/151633
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18359
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20030086904.pdf
[firstpage_image] =>[orig_patent_app_number] => 10151633
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/151633 | Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-α transgene | May 16, 2002 | Issued |
Array
(
[id] => 6261783
[patent_doc_number] => 20020187936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Methods of treating liver disease and liver damage with growth hormone and foxM1B'
[patent_app_type] => new
[patent_app_number] => 10/151587
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 23775
[patent_no_of_claims] => 144
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187936.pdf
[firstpage_image] =>[orig_patent_app_number] => 10151587
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/151587 | Methods of treating liver disease and liver damage with growth hormone and foxM1B | May 16, 2002 | Abandoned |
Array
(
[id] => 7275030
[patent_doc_number] => 20040234481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Gene transfers of angiogenic factor for skin disease'
[patent_app_type] => new
[patent_app_number] => 10/477166
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9562
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20040234481.pdf
[firstpage_image] =>[orig_patent_app_number] => 10477166
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/477166 | Method of treating skin wounds with vectors encoding hepatocyte growth factor | May 8, 2002 | Issued |
Array
(
[id] => 6843082
[patent_doc_number] => 20030148429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/141705
[patent_app_country] => US
[patent_app_date] => 2002-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63479
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148429.pdf
[firstpage_image] =>[orig_patent_app_number] => 10141705
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/141705 | Pro4399 Polypeptides | May 7, 2002 | Issued |
Array
(
[id] => 6773801
[patent_doc_number] => 20030017139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Regulatory elements for delivery to the liver'
[patent_app_type] => new
[patent_app_number] => 10/139763
[patent_app_country] => US
[patent_app_date] => 2002-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4086
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017139.pdf
[firstpage_image] =>[orig_patent_app_number] => 10139763
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/139763 | Regulatory elements for delivery to the liver | May 5, 2002 | Issued |
Array
(
[id] => 6692204
[patent_doc_number] => 20030039636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Novel self-inactivating (SIN) lentiviral vectors'
[patent_app_type] => new
[patent_app_number] => 10/137788
[patent_app_country] => US
[patent_app_date] => 2002-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10965
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20030039636.pdf
[firstpage_image] =>[orig_patent_app_number] => 10137788
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/137788 | Novel self-inactivating (SIN) lentiviral vectors | Apr 30, 2002 | Abandoned |
Array
(
[id] => 7199604
[patent_doc_number] => 20040205834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'System for inducible expression in eukaryotic cells'
[patent_app_type] => new
[patent_app_number] => 10/135362
[patent_app_country] => US
[patent_app_date] => 2002-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11609
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20040205834.pdf
[firstpage_image] =>[orig_patent_app_number] => 10135362
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/135362 | Cumate-inducible expression system for eukaryotic cells | Apr 30, 2002 | Issued |
Array
(
[id] => 6657119
[patent_doc_number] => 20030077829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Lipid-based formulations'
[patent_app_type] => new
[patent_app_number] => 10/136707
[patent_app_country] => US
[patent_app_date] => 2002-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11052
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077829.pdf
[firstpage_image] =>[orig_patent_app_number] => 10136707
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/136707 | Lipid-based formulations | Apr 29, 2002 | Abandoned |
Array
(
[id] => 7540405
[patent_doc_number] => 08058248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-15
[patent_title] => 'Foot and mouth disease virus vaccine comprising interferons'
[patent_app_type] => utility
[patent_app_number] => 10/128463
[patent_app_country] => US
[patent_app_date] => 2002-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 27
[patent_no_of_words] => 11567
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/058/08058248.pdf
[firstpage_image] =>[orig_patent_app_number] => 10128463
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/128463 | Foot and mouth disease virus vaccine comprising interferons | Apr 23, 2002 | Issued |
10/018729 | Regulation system of expression using nuclear ppar receptors | Apr 21, 2002 | Abandoned |
10/111052 | Nucleic acid transporter containing polypeptides and recombinat virus vector | Apr 18, 2002 | Abandoned |
Array
(
[id] => 6869466
[patent_doc_number] => 20030082155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Stem cells of the islets of langerhans and their use in treating diabetes mellitus'
[patent_app_type] => new
[patent_app_number] => 10/120687
[patent_app_country] => US
[patent_app_date] => 2002-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 25498
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082155.pdf
[firstpage_image] =>[orig_patent_app_number] => 10120687
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/120687 | Stem cells of the islets of langerhans and their use in treating diabetes mellitus | Apr 10, 2002 | Abandoned |
Array
(
[id] => 4916
[patent_doc_number] => 07812148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-12
[patent_title] => 'Vectors comprising CpG islands without position effect varigation and having increased expression'
[patent_app_type] => utility
[patent_app_number] => 10/117960
[patent_app_country] => US
[patent_app_date] => 2002-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 87
[patent_figures_cnt] => 31
[patent_no_of_words] => 11375
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/812/07812148.pdf
[firstpage_image] =>[orig_patent_app_number] => 10117960
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/117960 | Vectors comprising CpG islands without position effect varigation and having increased expression | Apr 4, 2002 | Issued |
Array
(
[id] => 6869996
[patent_doc_number] => 20030082685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Chemotherapeutic induction of egr-1 promoter activity'
[patent_app_type] => new
[patent_app_number] => 10/117442
[patent_app_country] => US
[patent_app_date] => 2002-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 27099
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082685.pdf
[firstpage_image] =>[orig_patent_app_number] => 10117442
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/117442 | Chemotherapeutic induction of egr-1 promoter activity | Apr 4, 2002 | Abandoned |
Array
(
[id] => 6682771
[patent_doc_number] => 20030118635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Polynucleotide binding complexes comprising sterols and saponins'
[patent_app_type] => new
[patent_app_number] => 10/114957
[patent_app_country] => US
[patent_app_date] => 2002-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 43894
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20030118635.pdf
[firstpage_image] =>[orig_patent_app_number] => 10114957
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/114957 | Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides | Apr 3, 2002 | Issued |
Array
(
[id] => 6864782
[patent_doc_number] => 20030190308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Adjuvant'
[patent_app_type] => new
[patent_app_number] => 10/102622
[patent_app_country] => US
[patent_app_date] => 2002-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 27329
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190308.pdf
[firstpage_image] =>[orig_patent_app_number] => 10102622
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/102622 | Adjuvant | Mar 18, 2002 | Abandoned |
Array
(
[id] => 6413871
[patent_doc_number] => 20020183333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Compositions and methods for chemotherapy having reduced nephrotoxicity'
[patent_app_type] => new
[patent_app_number] => 10/103520
[patent_app_country] => US
[patent_app_date] => 2002-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7271
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20020183333.pdf
[firstpage_image] =>[orig_patent_app_number] => 10103520
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/103520 | Compositions and methods for chemotherapy having reduced nephrotoxicity | Mar 18, 2002 | Abandoned |
Array
(
[id] => 6047962
[patent_doc_number] => 20020168739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Vectors, compositions and methods for treating a vascular disorder'
[patent_app_type] => new
[patent_app_number] => 10/094210
[patent_app_country] => US
[patent_app_date] => 2002-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7285
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168739.pdf
[firstpage_image] =>[orig_patent_app_number] => 10094210
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/094210 | Vectors, compositions and methods for treating a vascular disorder | Mar 7, 2002 | Abandoned |
Array
(
[id] => 6843074
[patent_doc_number] => 20030148421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Gene products that regulate glucose response in cells'
[patent_app_type] => new
[patent_app_number] => 10/080381
[patent_app_country] => US
[patent_app_date] => 2002-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 47773
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148421.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080381
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080381 | Gene products that regulate glucose response in cells | Feb 18, 2002 | Abandoned |
10/060069 | Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby | Jan 28, 2002 | Abandoned |